Health
Combination of SFRP2 and PD-1 immunotherapy halts aggressive metastatic cancer in preclinical model – News-Medical.Net
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new discoveries.
Using a combination of personal passion and expertise, Klauber-DeMore…
Continue Reading
-
General21 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Noosa News24 hours agoNSW records 100th e-rideable battery fire for 2025, prompting renewed safety calls
-
General23 hours agoOne of seven Rosenberg’s goannas from ACT reserve is missing from home for second time in two years
-
General18 hours agoHome of Andrii Yermak, Zelenskyy’s chief of staff, raided by anti-corruption unit